SEC Filing Summary: Amedica Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Amedica Corporation on October 13, 2015. The registrant is a Delaware corporation headquartered in Salt Lake City, Utah, specializing in medical devices for spine surgery.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a specific corporate event rather than financial performance data.
Material Changes and Events
- New Product Launch: Amedica announced the release of the Scorpion™ articulating inserter.
- System Compatibility: The new inserter is designed to accompany the Valeo II™ TL interbody fusion device system.
- Commercial Availability: The product is scheduled to be commercially available in mid-November 2015.
- Clinical Application: The device aids in minimally-invasive transforaminal lumbar interbody fusion surgeries.
Outlook, Risks, and Management Commentary
Management commentary is limited to the press release regarding the new product launch. The filing does not contain specific financial guidance, risk factors, contingencies, or unusual items beyond the standard disclosure of the new product availability.
Investor Verification Checklist
- Verify the commercial launch date of the Scorpion™ inserter in mid-November 2015.
- Confirm the integration capabilities of the Scorpion™ inserter with the existing Valeo II™ TL system.
- Review the press release (Exhibit 99.1) for detailed technical specifications and market strategy.
- Check subsequent filings for any financial impact or revenue recognition related to this new product line.